Raymond James lowered the firm’s price target on Braze (BRZE) to $43 from $48 and keeps an Outperform rating on the shares. Braze’s Q1 results exceeded expectations, though the magnitude of the upside and guidance may cause some near-term “indigestion,” the analyst tells investors in a research note. Raymond James view management’s move to de-risk the forward guide as providing a better setup for shares in future quarters, and believes the 9% pullback is a buying opportunity.
Don’t Miss TipRanks’ Half Year Sale
- Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BRZE:
- Braze price target lowered to $40 from $45 at Stifel
- Braze’s Strong Market Position and Growth Potential Justify Buy Rating
- Braze price target lowered to $44 from $51 at Oppenheimer
- Braze price target lowered to $41 from $51 at Stephens
- Braze’s Strong Performance and Strategic Acquisition Reinforce Buy Rating